For more information please contact us at [email protected].

Vantage BioTrials brings deep expertise in allergy clinical trials, supporting innovative immunotherapies and diagnostics with precision and operational excellence.

What Vantage BioTrials Brings to Allergy Studies

• Experience with SLIT, SCIT, anti-IgE biologics, allergen challenge models, and long-term follow-up.
• Diagnostic expertise including skin prick tests, serum IgE, food challenges, and centralized data review.
• Patient recruitment tailored to seasonal and environmental factors; multi-site/multi-country execution.
• Familiarity with PROs, QoL measures, anaphylaxis grading, and global regulatory expectations.
• Operational strength in cold chain logistics, site training, and standardized exposure protocols.

Vantage BioTrials excels in dermatology trials across different indications, ensuring high-quality execution and regulatory alignment.

What Vantage BioTrials Brings to Dermatology Studies

• Broad experience in psoriasis, atopic dermatitis (Eczema), and hidradenitis suppurativa (HS).
• Endpoint expertise: PASI, EASI, lesion counts, pruritus scores, QoL, and imaging tools.
• Management of topical/systemic therapies and dermatologic devices.
• Regulatory insight into chronic conditions and photosensitivity monitoring.
• Strong patient recruitment and risk-based monitoring for trial integrity.

Success Story

Vantage BioTrials was appointed by Abbvie to manage their Phase IV Post Market Observational Epidemiological clinical trial for hidradenitis suppurativa (a rare disease). The set enrollment expectation by the Abbvie was to recruit 145 patients across 30 Canadian sites within 24 months. This target was set as a realistic expectation given the complexity and challenge of finding patients with the disease, as well as finding health care providers and dermatologists with sufficient understanding of the rare condition.

Vantage BioTrials efficiently completed the study by accelerating the enrollment timeframe by 12 months with less sites involved. Click here to read more.

Developing the right approach by using protocol design input and working towards a specific regulatory claim and commercial application early in the life cycle is the fastest way to market for medical devices or in vitro diagnostics.

Vantage BioTrials has a deep understanding of the challenges faced in clinical development for medical devices: intense competition, precise regulatory requirements and shortened product exclusivity and life cycle. Medical devices are not like drugs or vaccines. They even differ greatly from each other. That’s why you need a Medical Device & Diagnostics group with the broad experience of our project teams. We have the capability to meet your clinical development needs for both pilot and pivotal studies using efficient study management strategies that can reduce costs and shorten time lines by:

• Developing a well-designed protocol and case report forms (CRFs) to ensure high quality data and efficient monitoring
• Site identification and feasibility analysis
• Support Services to meet ISO 14971-2012 “Application of risk management to medical devices” requirement; management procedures and practices to analyze, evaluate, control, and monitor risk relating to the safety of a medical device throughout the protocol design, development and product lifecycle
• Application to Health Authorities, IRB/EC submission, labeling assistance, and other global requirements. Efficiently managing study start up, and execution in accordance with ICH GCP & ISO 14155-2011
• Risk analysis/mitigation and risk-based monitoring approach

As one of the only Canadian CRO’s that has established a niche for the management of Medical Device trials, Vantage BioTrials has successfully obtained numerous agency approvals, PMAs and FDA 510(k) clearances.

Our experience includes:

• Proof of Concept Studies
• Companion Diagnostics
• Implantables
• Combined Device/Drug Systems
• Orthopedics

Vantage BioTrials will remain focused and dedicated to finding solutions for your study that will realize efficiency and productivity, all the while maintaining quality and keeping your study within cost and timelines. For more information or to request a proposal, please call 514-564-3466 or email us at [email protected].

Vantage BioTrials delivers high-quality study management in endocrinology and diabetes, supporting therapeutic and diagnostic development across all phases.

What Vantage BioTrials Brings to Endocrinology / Diabetes Studies

• Indications include Type 1/2 diabetes, obesity/weight loss, thyroid, adrenal, and metabolic disorders.
• Combination therapy/device trials with pens, pumps, CGMs, and injectables.
• Expertise in endpoints (HbA1c, hypoglycemia, weight loss), PK/PD, and long-term safety.
• Global regulatory compliance and real-world evidence generation.
• Operational strength in cold chain, biomarker management, and digital health integration.

Vantage BioTrials manages complex GI clinical trials with scientific depth, regulatory expertise, and operational precision.

What Vantage BioTrials Brings to Gastroenterology Studies

• Indications: IBD (Crohn’s, UC), IBS, liver disease, GI cancers, GERD, motility disorders.
• Endpoints: endoscopy, QoL, symptom scores, calprotectin, CRP, imaging, and biopsy handling.
• Trial design for induction/maintenance, surveillance, and biologics.
• Recruitment from GI centers with centralized reading and pathology support.
• Global regulatory experience with real-world studies and long-term follow-up.

With hundreds of Bioequivalence/Phase I clinical trials monitored to date for our Consumer Health, Generic Pharma, Biotechnology and Biopharma Sponsors, and in a multitude number of therapeutic areas, we are the only expert service provider in Canada with so much experience in handling these type of early-phase trials.

Our therapeutically experienced clinical trial specialists will ensure that your trial is managed and monitored properly and without compromising quality.  Through Risk-Based Monitoring, they will ensure:

• Interpreting the metrics, performance indicators, and trends that emerge from a combination of on-site and centralized monitoring to ensure proactive decision making and interventions.
• Continuous flow of study data that is being monitored for trends to enable real-time decision making and action.
• Qualitative reports.

Our experience includes:

• BE/BA
• PK/PD
• First in Human
• Multi/Single Ascending Dose
• Proof of Concept

Vantage BioTrials brings expert capabilities in hepatology clinical trials, advancing therapies for a wide spectrum of liver diseases.

What Vantage BioTrials Brings to Hepatology Studies

• Coverage includes hepatitis B/C, NAFLD/NASH, cirrhosis, HCC, cholangiocarcinoma, autoimmune and genetic liver diseases.
• Advanced endpoints: MRI, CT, elastography, liver enzymes, viral load, fibrosis scoring.
• Biopsy logistics, imaging reads, and recruitment of comorbid patients.
• Safety oversight for DILI, hepatotoxicity, and cirrhosis complications.
• High-quality data capture with centralized histology and PROs for chronic disease burden.

Vantage BioTrials supports immunology trials with scientific rigor, managing studies across autoimmune and immune-mediated diseases and advanced therapeutics.

What Vantage BioTrials Brings to Immunology Studies

• Broad indication support: Rheumatoid Arthritis (RA), multiple sclerosis (MS), lupus, Inflammatory Bowel Disease (IBD), autoimmune hepatitis and rare immunologic disorders.
• Modalities: monoclonal antibodies, cytokine inhibitors, gene/cell therapies.
• Biomarker-driven endpoints: flow cytometry, cytokines, autoantibodies, imaging.
• Safety expertise for immune risks, cytokine release, and long-term monitoring.
• Regulatory pathway support, central lab coordination, and global trial harmonization.

Vantage BioTrials is uniquely equipped to deliver rigorous, high-quality clinical trials in infectious diseases and vaccines. Leveraging scientific expertise, regulatory insight, and operational excellence, we support the development of vaccines, therapeutics, diagnostics, and public health interventions in this dynamic and critical field.

Our Strengths in Infectious Disease & Vaccine Trials

• Extensive Indication & Vaccine Coverage
  Trials spanning viral, bacterial, parasitic, emerging, vector-borne diseases, seasonal and pandemic vaccines; therapeutic antivirals, antibacterials, antifungals, and tropical disease treatments.
• Diverse Vaccine Platforms
  Experience with mRNA, viral vector, subunit/conjugate, live attenuated, and inactivated vaccines.
• Regulatory & Endpoint Expertise
  In-depth knowledge of correlates of protection, neutralizing antibody and T-cell immune responses, functional assays, challenge models, adjuvant safety, prime-boost strategies, manufacturing compliance, and global regulatory pathways (FDA, EMA, WHO).
• Operational Excellence & Logistics
  Strategic site selection in endemic regions, diverse population recruitment, expert cold chain and biosecurity management, integrated diagnostics (serology, PCR, viral load), centralized labs, and biomarker/immunogenicity testing.
• Adaptive Trial Design & Seasonal Considerations
  Adaptive, phase-gated designs; multi-site/multi-region coordination; timing for seasonality and variant monitoring.
• Safety, Monitoring & Post-Marketing Expertise
  Vigilant safety surveillance including reactogenicity and rare adverse events; vaccine effectiveness studies, diagnostic validation, and real-world evidence generation.
• Collaborations & Global Health Partnerships

Partner with Vantage BioTrials to advance your infectious disease and vaccine programs with the scientific rigor, regulatory acumen, and operational strength needed to succeed globally.

Vantage BioTrials offers robust expertise in mental health clinical research, supporting neuropsychiatric and psychological disorders with innovative trial designs and patient-focused approaches.

What Vantage BioTrials Brings in Mental Health

• Broad therapeutic coverage including depression, bipolar disorder, schizophrenia, anxiety, PTSD, substance abuse, neurodevelopmental and neurocognitive disorders.
• Expertise in validated psychiatric scales (HAM-D, MADRS, PANSS), patient-reported outcomes, cognitive and digital biomarkers.
• Innovative designs: placebo-controlled, active comparator, adaptive, and decentralized trials.
• Comprehensive safety monitoring addressing psychiatric adverse events and suicidality with long-term follow-up.
• Access to specialized sites and remote assessment capabilities ensuring regulatory compliance.

Vantage BioTrials provides extensive capabilities in nephrology, supporting drug and diagnostic development for kidney diseases including CKD, AKI, and dialysis.

What Vantage BioTrials Brings to Nephrology Studies

• Indication breadth: CKD, diabetic nephropathy, glomerulonephritis, AKI, ESRD, dialysis, transplantation.
• Expertise in renal biomarkers (eGFR, creatinine clearance), proteinuria, histopathology, and surrogate endpoints.
• Strong trial design and operational execution, recruiting from nephrology clinics and dialysis centers.
• Safety and regulatory compliance for renal safety signals and electrolyte management.
• High standards in data integrity with central labs, risk-based monitoring, and patient-centric data tools.

Vantage BioTrials delivers deep oncology and hematology expertise, supporting precision medicine, immunotherapy, and cell therapy development across hematologic and solid tumors.

What Vantage BioTrials Brings to Oncology / Hematology Studies

• Comprehensive support for solid tumors and hematologic malignancies (leukemia, lymphoma, myeloma, MDS, MPN).
• Experience with biomarker-driven trials, genomic profiling, immune checkpoint inhibitors, CAR-T, and cell therapies.
• Advanced endpoint management: RECIST, MRD, PFS, OS, and patient-reported outcomes.
• Global operational capabilities with specialized sites, investigational product logistics, biospecimen handling, and centralized imaging.
• Safety monitoring for immune-related AEs and regulatory expertise across regions.
• Cutting-edge data management including ePROs and real-world evidence support.

Vantage BioTrials offers comprehensive clinical trial support in ophthalmology across diverse ocular diseases, from early to late phase, focusing on quality and regulatory compliance.

What Vantage BioTrials Brings to Ophthalmology Studies

• Coverage of diabetic retinopathy, AMD, glaucoma, dry eye, uveitis, retinal vascular disorders.
• Tailored protocol development targeting ocular endpoints and imaging biomarkers.
• Site feasibility, patient recruitment, centralized reading, imaging standardization, and ophthalmic-specific data management.
• Robust safety monitoring and regulatory support with ocular-specific adjudication.
• Risk-based monitoring and quality oversight ensuring high data reliability.

Pediatric clinical trials present unique challenges, including ethical considerations, limited patient populations, developmental variability, and complex regulatory requirements. Trials must account for age-specific pharmacokinetics, informed consent/assent, and child-friendly formulations—all while ensuring patient safety and long-term follow-up.

Vantage BioTrials specializes in addressing these complexities to support the safe and effective development of pediatric drugs, devices, and diagnostics across all trial phases.

Key Strengths:

• Broad Therapeutic Coverage
  Experience across infectious diseases, rare genetic conditions, oncology, neonatology, metabolic disorders, and chronic pediatric diseases.
• Age-Appropriate Trial Design
  Tailored protocols including pediatric-specific endpoints (growth, development, PK/PD), formulations, dosing, and PROs.
• Ethical & Regulatory Expertise
  Skilled in managing informed consent/assent, safety in vulnerable populations, and compliance with global pediatric regulations (e.g., FDA, EMA, ICH E11).
• Operational Capabilities
  Access to specialized pediatric sites and investigators, strategies for recruiting and retaining pediatric populations, and family-centered trial support.
• Safety Monitoring & Long-Term Follow-up
  Vigilant tracking of pediatric-specific adverse events and implementation of safety protocols throughout extended observation periods.

Vantage BioTrials ensures quality, ethical integrity, and regulatory alignment in pediatric trials—helping sponsors bring safe, effective therapies to children with confidence.

Vantage BioTrials offers specialized expertise in managing clinical trials for radiopharmaceuticals, including both diagnostic and therapeutic radioactive agents. We support sponsors with the technical, regulatory, and operational rigor required for this complex field.

Key Strengths:

• Multidisciplinary Coordination
  Expertise working with nuclear medicine teams, radiochemists, and imaging specialists to streamline trial execution.
• Operational & Cold Chain Logistics
  Handling of radioactive materials with site licensing, transport compliance, and cold chain management.
• Imaging & Dosimetry Expertise
  Standardized PET/SPECT imaging, biodistribution assessments, and centralized imaging reviews.
• Adjudication & Safety Oversight
  Independent adjudication committees (IACs) for efficacy endpoints and radiation-related adverse events, ensuring objective data validation.
• Regulatory Compliance
  Adherence to regional and global regulations (e.g., FDA, EMA, CNSC) and radiation safety protocols.
• Patient-Centric Design
  Informed consent tailored to radioactive exposure and coordinated multidisciplinary care.

Vantage BioTrials ensures precision, compliance, and safety in radiopharmaceutical trials—delivering high-quality data across highly specialized studies.

Rare disease/orphan drug trials have unique challenges with respect to clinical trial management, investigator/site selection, and patient recruitment/retention. Ensuring the implementation of Risk Mitigation strategies throughout the lifecycle of the trial is key in assisting with the identification of several critical factors:

• Understanding and maintaining strong collaborations with patient advocacy groups and key opinion leaders to create deeper study awareness and support.
• Ensuring that trial protocols are realistic given any limitations of the target patient population.
• Engaging physicians with pediatric experience to understand the study design and complexity involved.
• Remaining patient focused to boost trial enrollment and retention by providing quality subject support materials to demonstrate the benefits of participation.
• Creating a set of study branded tools to help sites identify potential patients as well as educate them about the study and its requirements.
• Regulatory understanding and consultation surrounding the unique environment for rare disease studies.
• Site relationships with access to patient registries to drive patient enrollment.

Our experience includes:

• Multiple Sclerosis
• Rare Cancers (such as Adrenocortical Carcinoma (ACC), Glioblastoma, Esophageal cancer, Chronic Myeloid Leukemia)
• Rare Eye Diseases (such as Wet AMD, Diabetic Retinopathy, Retinitis Pigmentosa)
• Porphyria
• Cushing’s Syndrome
• Cystic Fibrosis
• Familial Hypercholesterolemia
• Fibrodysplasia
• Gastroparesis
• Glomerulonephritis
• Hidradenitis Supurattiva (HS)
• Renal Vasculitis
• Tinnitus

Vantage BioTrials will remain focused and dedicated to finding solutions for your study that will realize efficiency and productivity, all the while maintaining quality and keeping your study within cost and timeline. For more information or to request the proposal, please email us at [email protected].

Vantage BioTrials delivers comprehensive respiratory clinical trial expertise across pulmonary diseases with advanced endpoints and operational excellence.

What Vantage BioTrials Brings to Respiratory Studies

• Therapeutic scope including asthma, COPD, cystic fibrosis, interstitial lung diseases, pulmonary hypertension, and respiratory infections.
• Endpoint expertise: spirometry, diffusing capacity, HRCT imaging, biomarkers (eosinophils, FeNO), exacerbation rates, QoL measures.
• Experience with inhalation device trials, adaptive designs, and global recruitment from specialized centers.
• Safety monitoring aligned with global respiratory guidelines and management of comorbidities.
• Use of digital tools, home spirometry, ePROs, and remote monitoring to enhance data quality and retention.

Vantage BioTrials offers expertise in rheumatology and musculoskeletal diseases, supporting therapies for inflammatory, autoimmune, and degenerative conditions.

What Vantage BioTrials Brings to Rheumatology / Musculoskeletal Studies

• Broad indication coverage including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, osteoarthritis, gout.
• Experience with ACR response criteria, DAS28, imaging scores, biomarker assays, and functional disability scales.
• Access to specialized sites, expert investigators, and patient registries enhancing recruitment.
• Safety and regulatory compliance for immunosuppression risks and infections.
• High-quality data capture via ePROs, wearables, and centralized imaging reads.

Vantage BioTrials provides strong capabilities in urology clinical research, covering benign and malignant urologic diseases.

What Vantage BioTrials Brings to Urology Studies

• Diverse indications including BPH, urinary incontinence, erectile dysfunction, prostate and bladder cancers, kidney stones.
• Expertise with urodynamics, imaging, patient-reported outcomes, and relevant biomarkers.
• Operational proficiency with site selection in urology centers and coordination of device/procedural trials.
• Safety monitoring for treatment and surgical complications with regulatory compliance.
• Innovative data management integrating digital health tools and remote monitoring.